Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Fidus Investment Corp. (NASDAQ: FDUS) shares spiked 7.17 percent to close at $19.14 a share Friday. The stock traded between $18.26 and $19.44 on volume of 275,561 shares traded. Analysts at Raymond James have recently upgraded the company's rating to "strong buy" from "outperform". Shares of Fidus Investment have fallen approximately 12.0 percent year-to-date.
Find out more about Fidus Investment including full access to the free equity report at:
Genesis Energy, L.P. (NYSE: GEL) shares declined 0.26 percent to close at $53.33 a share Friday. The stock traded between $52.57 and $53.82 on volume of 217,706 shares traded. Analysts at Citigroup have recently downgraded the company's rating to "neutral" from "buy". Shares of Genesis Energy have gained approximately 1.5 percent year-to-date.
Find out more about Genesis Energy including full access to the free equity report at:
Dr. Reddy's Laboratories Limited (NYSE: RDY) shares increased 1.92 percent to close at $43.95 a share Friday. The stock traded between $43.31 and $44.12 on volume of 501,119 shares traded. Analysts at TheStreet Ratings maintain have recently upgraded the company's rating to "hold" from "buy". Shares of Dr. Reddy's Laboratories have fallen approximately 7.0 percent year-to-date.
Find out more about Dr. Reddy's Laboratories including full access to the free equity report at:
Synergy Resources Corp. (NYSEMKT: SYRG) shares increased 6.49 percent to close at $10.67 a share Friday. The stock traded between $10.32 and $10.67 on volume of 749,577 shares traded. Analysts at Imperial Capital have recently initiated coverage on the company with an "outperform" rating. Shares of Synergy Resources have gained approximately 15.0 percent year-to-date.
Find out more about Synergy Resources including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing